Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Schweiz Arch Tierheilkd ; 160(2): 95-105, 2018 Feb.
Article in German | MEDLINE | ID: mdl-29386166

ABSTRACT

INTRODUCTION: Feline leukemia virus (FeLV) leads to fatal disease in cats with progressive infection. The aim of this study was to determine the importance of FeLV infection in Switzerland and make a comparison with previous studies. Of 881 blood samples taken from cats living in Switzerland (minimum of 20 samples per Canton), 47 samples were provirus-positive (5.3%; 95% confidence interval (CI) 3.9-7.0%) and 18 samples were antigen-positive (2%; 95% CI 1.2-3.2%). Together with data previously collected in similar studies, these findings demonstrated a decrease in prevalence between 1997 and 2003 followed by a relative constant low prevalence thereafter. Young cats (=2 years) were more frequently infected than older cats, but FeLV-positive cats were up to 15 (antigen-positive) and 19 (provirus-positive) years old. Sexually intact cats were more frequently viremic than neutered cats; purebred cats were somewhat less frequently FeLV-positive than non-purebred cats. In a second study, in which 300 saliva samples were analyzed, samples from 5 cats were FeLV-RNA positive (1.7%; 95% CI, 0.5-3.8%), although one young feral cat had been falsely assumed to be FeLV-negative based on a point-of-care test. Of the 300 cats, only 50% were FeLV tested or vaccinated, although 90% of the cats were at risk of exposure to FeLV. Testing and vaccination of all cats with exposure risk may help further decrease the prevalence of FeLV infection. Moreover, characteristics of FeLV tests should be considered, such as the risk of false negative results in the early phase of infection when performing antigen testing.


INTRODUCTION: Le virus leucémogène félin (FeLV) conduit la plupart du temps à une maladie mortelle chez le chat avec une infection progressive. Le but du présent travail est de mettre en évidence l'importance de l'infection à FeLV en Suisse sur la base de recherches actuelles et de la comparer avec les résultats de recherches antérieures. Afin de répondre à la question de savoir combien de chats présentés à la consultation étaient porteurs du FeLV (positifs au provirus) respectivement excréteurs de FeLV (positifs à l'antigène), on a analysé 881 échantillons sanguins provenant de toute la Suisse (au minimum 20 par canton) : 47 échantillons étaient positifs au provirus (5.3%; 95% intervalle de confiance (CI) 3.9­7.0%) et 18 positifs à l'antigène (2%; 95% CI 1.2­3.2%). Une comparaison avec des recherches semblables faites antérieurement montre que la prévalence du FeLV a diminué entre 1997 et 2003 mais qu'elle stagne depuis lors. Actuellement ce sont plutôt les jeunes chats (=2 ans) qui sont touchés plutôt que les vieux; des chats ont toutefois été trouvés positifs jusqu'à l'âge de 15 ans (positifs à l'antigène) respectivement de 19 ans (positifs au provirus). Les chats non castrés étaient plus souvent virémiques que les castrés et les chats de races étaient aussi, mais un peu moins fréquemment FeLV-positifs. Dans une autre étude suisse, dans laquelle 300 échantillons de salive de chats ont été testés quant à la présence d'ARN-FeLV, 5 chats étaient excréteurs (1.7%; 95% CI 0.5­3.8%). Un jeune chat trouvé, qui avait été testé négatif au test rapide, a été trouvé infecté par le FeLV au moyen de la mise en évidence d'ARN. Sur ces 300 chats, seuls environ 50% avaient été testés quant au FeLV respectivement vaccinés, bien qu'environ 90% aient présenté un risque d'exposition au FeLV. Pour diminuer encore la prévalence du FeLV, il conviendrait de tester et de vacciner tous les chats avec un risque d'exposition au virus. Dans ce contexte, il faut tenir compte des différentes caractéristiques des tests comme la non reconnaissance de la phase d'infection très précoce au moyen du test FeLV rapide.


Subject(s)
Leukemia Virus, Feline/isolation & purification , Leukemia, Feline/epidemiology , Retroviridae Infections/veterinary , Tumor Virus Infections/veterinary , Animals , Cats , Leukemia, Feline/virology , Retroviridae Infections/epidemiology , Retroviridae Infections/virology , Switzerland/epidemiology , Tumor Virus Infections/epidemiology , Tumor Virus Infections/virology
2.
Schweiz Arch Tierheilkd ; 156(7): 345-8, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24973323

ABSTRACT

A 22-year old mare from Switzerland was admitted to an equine clinic in May 2011. She presented with fever, lethargy, icteric mucous membranes, reduced alertness, an unsteady gait and ataxia. An Anaplasma phagocytophilum infection was confirmed by blood smear and PCR. The mare was treated with oxytetracylin and recovered rapidly, but she still suffered from a slight atactic gait disturbance at 3 weeks post infection.


Subject(s)
Anaplasma phagocytophilum , Ehrlichiosis , Horse Diseases , Animals , Anti-Bacterial Agents/therapeutic use , Ehrlichiosis/diagnosis , Ehrlichiosis/drug therapy , Ehrlichiosis/physiopathology , Ehrlichiosis/veterinary , Female , Horse Diseases/diagnosis , Horse Diseases/drug therapy , Horse Diseases/physiopathology , Horses , Molecular Sequence Data , Oxytetracycline/therapeutic use , Switzerland
3.
Schweiz Arch Tierheilkd ; 154(4): 149-52, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22563611

ABSTRACT

The following report describes the direct detection of Ehrlichia canis by real-time PCR in the conjunctiva of a 1-year-old female Maltese dog. After being imported from Brazil, the dog was presented because of anorexia, dehydration, fever, and palpable mandibular lymph nodes. A few days later, the dog developed bilateral blepharospasm, photophobia and anterior uveitis. Monocytic ehrlichia was diagnosed by a positive PCR result and the detection of IgM and IgG antibodies. Because of the massive uveitis a conjunctival sample was taken with a cytobrush, which also tested positive for Ehrlichia canis DNA by real-time PCR. Only one week after starting treatment with systemic doxycycline and local anti-inflammatory and cyclopalgic therapy the dog recovered from systemic and eye diseases. After therapy the follow-up examination revealed a full remission of clinical and hematological parameters and negative PCR result.


Subject(s)
Dog Diseases/diagnosis , Ehrlichia canis/isolation & purification , Ehrlichiosis/veterinary , Real-Time Polymerase Chain Reaction/veterinary , Uveitis, Anterior/veterinary , Animals , DNA, Bacterial/blood , Dog Diseases/drug therapy , Dog Diseases/microbiology , Dogs , Ehrlichia canis/genetics , Ehrlichiosis/diagnosis , Ehrlichiosis/drug therapy , Ehrlichiosis/microbiology , Female , Ophthalmoscopy/veterinary , Tonometry, Ocular/veterinary , Uveitis, Anterior/diagnosis , Uveitis, Anterior/drug therapy , Uveitis, Anterior/microbiology
4.
Schweiz Arch Tierheilkd ; 151(7): 336-41, 2009 Jul.
Article in German | MEDLINE | ID: mdl-19565457

ABSTRACT

The following case report describes the diagnosis and therapy of a cat with an Anaplasma phagocytophilum infection. The cat from the canton of St. Gallen was presented because of lethargy and lack of appetite. The clinical symptoms established were fever and minor exsiccosis. The diagnosis of granulocytic anaplasmosis was established through microscopic evidence of inclusion bodies in neutrophil granulocytes, the detection of pathogen DNA in the blood by PCR and positive IgM and IgG antibody titers by serological testing. Following this diagnosis the cat was treated for 20 days with doxycycline. As the body temperature normalised, the activity of the cat improved while normalisation of food intake was delayed. After therapy Anaplasma phagocytophilum DNA could not be detected by PCR and a complete remission of abnormal serum chemistry and hematological parameters could be shown.


Subject(s)
Anaplasma phagocytophilum/isolation & purification , Anti-Bacterial Agents/therapeutic use , Cat Diseases/diagnosis , Cat Diseases/drug therapy , Doxycycline/therapeutic use , Ehrlichiosis/veterinary , Animals , Cats , DNA, Bacterial/analysis , Ehrlichiosis/diagnosis , Ehrlichiosis/drug therapy , Male , Polymerase Chain Reaction/veterinary , Switzerland , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...